Tivicay
Tivicay

8.18
For patients managing HIV, this generic medicine interrupts the viral replication cycle by inhibiting the essential enzymes required for genomic integration.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Dolutegravir sodium
Reference Brand
Dolutegravir
Product Origin
Generic Alternative
Reference Manufacturer
ViiV Healthcare
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antivirals
Product Category
Integrase Strand Transfer Inhibitor (INSTI)
Pharmacological Class
Antiretroviral
Manufacturer Description
Formulated to alleviate retroviral disease to support immune preservation and target viral integrase enzymes.
Mechanism of Action
Binds directly to active site of viral integrase, preventing host chromosome insertion of viral DNA.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Concurrent dofetilide use, Hypersensitivity to dolutegravir
Severe Adverse Events
Hepatotoxicity — requires immediate medical attention, Severe hypersensitivity reactions — requires immediate medical attention
Common Side Effects
Headache, Insomnia, Nausea
Uncommon Side Effects
Fatigue, Diarrhea, Elevated blood lipids
Drug Interactions
Antacids, Rifampin, Carbamazepine
Pregnancy Safety Warnings
TGA Category B: Safety verified. Avoid in first trimester unless benefits justify risks. Breastfeeding: Avoid.
Age Restrictions
Approved for pediatric patients over four weeks and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Tivicay is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to order Birth Control Pills AU - Drospirenone Ethinyl Estradiol Low-Dose OCP